
Perspectives on Enquiry & Evidence
Cytel's blog featuring the latest industry insights.

February 7, 2023
GSK plans expansion of Solara clinical trial strategy platform to optimize design selection across therapeutic areas
Read article

November 16, 2022
Cytel’s Solara wins 2022 Fierce Innovation Award
Solara clinical trial strategy platform recognized for transformative innovation WALTHAM, MASS - Cytel Inc., a...
Read article

October 19, 2022
Cytel's Solara® Named Fierce Life Sciences Innovation Finalist for Technology
WALTHAM, MASS - Cytel Inc., creators of Solara®, a platform for high-compute, simulation-guided clinical trial...
Read article

March 22, 2022
Analytics and Innovation Available to Clinicians in Drug Development
WALTHAM, MASS - Cytel Inc. has appointed Albert Kim, MD, PhD, as its first Chief Medical Officer (CMO), driving...
Read article

December 17, 2021
Cytel's 2021 Webinars
Cytel believes dialogue is pivotal towards progress. Here are a list of our 2021 webinars. The Long-term Industry...
Read article

August 26, 2021
Cytel’s Solara Selected as 2021 Citeline Awards Finalist
Updated March 1, 2022: Cytel will be attending the Citeline awards ceremony in April. WALTHAM, MASS - Cytel’s new trial...
Read article

March 29, 2021
General Release of Solara & New Trial Optimization Program for Biotechs
WALTHAM, MASS - After months of successfully deploying its new strategic decision-support software Solara, Cytel Inc.,...
Read article